0001104659-24-019703.txt : 20240213 0001104659-24-019703.hdr.sgml : 20240213 20240213140443 ACCESSION NUMBER: 0001104659-24-019703 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 EFFECTIVENESS DATE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC CENTRAL INDEX KEY: 0001704132 ORGANIZATION NAME: IRS NUMBER: 821204449 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18415 FILM NUMBER: 24624585 BUSINESS ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001704132 XXXXXXXX 12-31-2023 12-31-2023 false Foresite Capital Management IV, LLC

900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939

13F HOLDINGS REPORT 028-18415 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 02-13-2024 0 5 197872800 INFORMATION TABLE 2 infotable.xml Kinnate Biopharma Inc. COM 49705R105 22921794 9671643 SH SOLE 9671643 0 0 Kura Oncology, Inc. COM 50127T109 26602238 1849947 SH SOLE 1849947 0 0 Lyell Immunopharma, Inc. COM 55083R104 16150500 8325000 SH SOLE 8325000 0 0 Pharvaris N.V. COM N69605108 113289518 4038842 SH SOLE 4038842 0 0 Syndax Pharmaceuticals, Inc. COM 87164F105 18908750 875000 SH SOLE 875000 0 0